中成药
中成藥
중성약
CHINESE TRADITIONAL PATENT MEDICINE
2010年
1期
22-25
,共4页
方欣%王斌%李伟%管思明
方訢%王斌%李偉%管思明
방흔%왕빈%리위%관사명
复方黄连%血管钙化%骨保护素%大鼠
複方黃連%血管鈣化%骨保護素%大鼠
복방황련%혈관개화%골보호소%대서
Compound Rhizoma Coptidis%vascular calcification%osteoprotegerin%rat
目的:研究复方黄连制剂(黄连、黄芩、黄柏、栀子和甘草)对华法令和维生素D_3诱发大鼠血管中膜钙化的干预效应.方法:SD大鼠40只,随机分成对照组、钙化组、复方黄连制剂预防组、复方黄连制剂治疗组.钙化组与药物干预组均给予华法令和维生素D_3诱导大鼠血管钙化模型,复方黄连制剂预防组在制作模型前3天给予复方黄连制剂,治疗组则在模型制作完成后给予复方黄连制剂.对照组给予生理盐水.4周后,比较各组Von Kossa染色及血管组织中钙含量,以及血管壁骨保护素(OPG)mRNA和蛋白表达.结果:32只大鼠最终进入结果分析.与对照组比较,钙化组Von Kossa染色显示血管中膜有明显钙沉积,血管组织中钙含量显著增高,分别为(608.32±42.29)μg/g,(1 139.47±230.03)μg/g;血管壁OPGmRNA和蛋白表达则明显减少.预防及治疗应用复方黄连制剂,血管中膜钙化明显改善,血管壁钙含量显著降低,分别为(854.77±12.99)μg/g,(875.78±27.23)μg/g;血管壁OPGmRNA和蛋白也显著增加.与钙化组比较,差异均有统计学意义(P<0.05).结论:预防或治疗使用复方黄连制剂可能通过增加血管壁骨保护素水平,明显改善血管中膜钙化.
目的:研究複方黃連製劑(黃連、黃芩、黃柏、梔子和甘草)對華法令和維生素D_3誘髮大鼠血管中膜鈣化的榦預效應.方法:SD大鼠40隻,隨機分成對照組、鈣化組、複方黃連製劑預防組、複方黃連製劑治療組.鈣化組與藥物榦預組均給予華法令和維生素D_3誘導大鼠血管鈣化模型,複方黃連製劑預防組在製作模型前3天給予複方黃連製劑,治療組則在模型製作完成後給予複方黃連製劑.對照組給予生理鹽水.4週後,比較各組Von Kossa染色及血管組織中鈣含量,以及血管壁骨保護素(OPG)mRNA和蛋白錶達.結果:32隻大鼠最終進入結果分析.與對照組比較,鈣化組Von Kossa染色顯示血管中膜有明顯鈣沉積,血管組織中鈣含量顯著增高,分彆為(608.32±42.29)μg/g,(1 139.47±230.03)μg/g;血管壁OPGmRNA和蛋白錶達則明顯減少.預防及治療應用複方黃連製劑,血管中膜鈣化明顯改善,血管壁鈣含量顯著降低,分彆為(854.77±12.99)μg/g,(875.78±27.23)μg/g;血管壁OPGmRNA和蛋白也顯著增加.與鈣化組比較,差異均有統計學意義(P<0.05).結論:預防或治療使用複方黃連製劑可能通過增加血管壁骨保護素水平,明顯改善血管中膜鈣化.
목적:연구복방황련제제(황련、황금、황백、치자화감초)대화법령화유생소D_3유발대서혈관중막개화적간예효응.방법:SD대서40지,수궤분성대조조、개화조、복방황련제제예방조、복방황련제제치료조.개화조여약물간예조균급여화법령화유생소D_3유도대서혈관개화모형,복방황련제제예방조재제작모형전3천급여복방황련제제,치료조칙재모형제작완성후급여복방황련제제.대조조급여생리염수.4주후,비교각조Von Kossa염색급혈관조직중개함량,이급혈관벽골보호소(OPG)mRNA화단백표체.결과:32지대서최종진입결과분석.여대조조비교,개화조Von Kossa염색현시혈관중막유명현개침적,혈관조직중개함량현저증고,분별위(608.32±42.29)μg/g,(1 139.47±230.03)μg/g;혈관벽OPGmRNA화단백표체칙명현감소.예방급치료응용복방황련제제,혈관중막개화명현개선,혈관벽개함량현저강저,분별위(854.77±12.99)μg/g,(875.78±27.23)μg/g;혈관벽OPGmRNA화단백야현저증가.여개화조비교,차이균유통계학의의(P<0.05).결론:예방혹치료사용복방황련제제가능통과증가혈관벽골보호소수평,명현개선혈관중막개화.
AIM:To investigate the effects of Compound Rhizoma Coptidis ( Rhizoma eoptidis,Radix suctellariae,Cortex phellodendri Chinensis,Fructus gardeniae and Radix et Rhizoma glycyrrhizae) on vascular calcification in rats treated with warfarin and vitamin D_3.METHODS: Thirty-two male SD rats were assigned randomly into control group,calcified group,Compound Rhizoma Coptidis prevented group and treated group.The later three groups were treated with warfarin,and subcutaneously injected with vitamin K_1 and vitamin D_3 for one week to induce extensive calcification of the aorta.Compound Rhizoma Coptidis was given before the first warfarin dose in prevented group and the drug was given after the modeling in the treated group.The control group was treated with normal saline.The calcification in the aorta was analyzed and osteoprotegerin (OPG) mRNA and protein were determined using histomorphometry,RT-PCR and immunohistoehemistry after 4 weeks of drug intervention.RESULTS : The results of 32 rats was analyzed compared to the control group,the area of darkly stained regions by Von Kossa staining and the level of calcium content in aorta wall increased significantly[(608.32±42.29) μg/g vs (1 139.47±230.03) μg/g,P <0.05].The OPGmRNA and protein decreased in aortic sections.No artery calcification could be detected in Compound Rhizoma Coptidis prevented group and a little artery calcification could be detected in Compound Rhizoma Coptidis treated group.The level of calcium content in aorta wall significantly lower[(854.77±12.99) μg/g,(875.78±27.23 ) μg/g].The expresion of OPGmRNA and the protein significanfly increased in Compound Rhizoma Coptidis prevented and treated groups.CONCLUSION:Compound Rhizo-ma Coptidis may prevent or regress the vegcular calcifiation,that seems dependent on the upregression of aortic OPG levels.